Loading
A phase 1/2 trial in colorectal cancer, run by Oslo University Hospital, now recruiting.
Partial Liver Segment 2/3 Transplantation Study is a phase 1/2, interventional study registered as NCT02215889 by Oslo University Hospital, with a registry enrolment figure of 20 participants, started 2014-06 and due to reach its primary completion in 2025-06. Interventions recorded: Liver transplantation. Conditions listed: Colorectal Cancer. Primary outcome: Percent of transplanted patients receiving second stage hepatectomy within 4 weeks of segment 2/3 transplantation.. Colorectal eligibility wording from the registry: "* Histologically verified adenocarcinoma in colon/rectum". Sites: Norway. No results are recorded here; the registry entry is the source.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.